Audio
Archive
2013
January
February
March
April
May
2012
January
February
March
April
May
June
July
August
September
October
November
December
2011
January
February
March
April
May
June
July
August
September
October
November
December
2010
January
February
March
April
May
June
July
August
September
October
November
December
2009
January
February
March
April
May
June
July
August
September
October
November
December
2008
January
February
March
April
May
June
July
August
September
October
November
December
2007
June
July
August
September
October
November
December
Subscribe
Nov. 07, 2008
Diabetes Research News
|
|
|
Tweet |
| In this segment, we'll get the latest on efforts to control Type 2 diabetes, the form in which the body gradually loses the ability to use insulin to control sugar levels in the blood. Two papers published this month in the journal Cell Metabolism present different approaches to controlling glucose levels in people with the condition. In one, a hormone called apelin, which is produced in fat tissues, was injected intravenously into normal and obese mice, and was found to significantly reduce blood sugar levels. In another study, researchers used an experimental drug manufactured by GlaxoSmithKline that mimics the behavior of resveratrol, a compound found in red wine and grapes. The artificial resveratrol decreased blood sugar levels and restored insulin levels to normal in diabetic mice. We'll talk about the two approaches, and other work on treating diabetes. |
Produced by Annette Heist, Senior Producer
Guests
-
C. Ronald Kahn
Mary K. Iacocca Professor of Medicine
Harvard Medical School
Vice Chairman of the Board and Section Head
Joslin Diabetes Center
Boston, Massachusetts


Discussion